SOPHiA GENETICS (SOPH) Revenue (2020 - 2025)

SOPHiA GENETICS has disclosed Revenue across 6 years of filings, most recently posting $21.7 million for Q4 2025.

• Revenue for Q4 2025 came in at $21.7 million, up 22.41% year-over-year; the trailing twelve-month figure through Dec 2025 was $77.3 million (up 18.56% YoY), and the FY2025 annual result was $77.3 million, up 18.56% from the prior year.
• Revenue came in at $21.7 million for Q4 2025 at SOPHiA GENETICS, up from $19.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $21.7 million in Q4 2025 to a low of $9.0 million in Q1 2021.
• The 5-year median for Revenue is $15.4 million (2023), against an average of $14.6 million.
• Across the five-year window, Revenue tumbled 99.86% in 2021 and surged 39.96% in 2023, its largest moves.
• SOPHiA GENETICS's Revenue stood at $10.9 million in 2021, then rose by 22.37% to $13.4 million in 2022, then climbed by 27.38% to $17.0 million in 2023, then rose by 4.02% to $17.7 million in 2024, then grew by 22.41% to $21.7 million in 2025.
• The last three Revenue figures came in at $21.7 million (Q4 2025), $19.5 million (Q3 2025), and $18.3 million (Q2 2025), per Business Quant data.